Profile
Irene Pleasure is currently the Vice President-Intellectual Property at Achaogen, Inc. Prior to this, she worked at Genentech, Inc. as a Senior Associate General Counsel from 2003 to 2017.
She also held positions at Roche Holding AG and Vir Biotechnology, Inc. as a Member and Senior Vice President & General Counsel, respectively.
Ms. Pleasure holds a doctorate degree from Thomas Jefferson University, an undergraduate degree from the University of Pennsylvania, and a graduate degree from The Santa Clara University School of Law.
Former positions of Irene Pleasure
| Companies | Position | End |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | General Counsel | 2022-02-28 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 2017-03-31 |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
| ACHAOGEN | Corporate Officer/Principal | - |
Training of Irene Pleasure
| Thomas Jefferson University | Doctorate Degree |
| University of Pennsylvania | Undergraduate Degree |
| The Santa Clara University School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Irene Pleasure
